Multiple therapeutic options exist for moderate-to-severe psoriasis, each with unique benefits and limitations. This review offers guidance on choosing the optimal therapy for your patients.
American Journal of Clinical Dermatology
Original Article: First-Line Biologics for Moderate-to-Severe Psoriasis